U.S. Markets closed
  • S&P 500

    4,432.99
    -40.76 (-0.91%)
     
  • Dow 30

    34,584.88
    -166.44 (-0.48%)
     
  • Nasdaq

    15,043.97
    -137.96 (-0.91%)
     
  • Russell 2000

    2,236.87
    +3.96 (+0.18%)
     
  • Crude Oil

    71.96
    -0.65 (-0.90%)
     
  • Gold

    1,752.20
    -4.50 (-0.26%)
     
  • Silver

    22.42
    -0.33 (-1.44%)
     
  • EUR/USD

    1.1732
    -0.0040 (-0.3402%)
     
  • 10-Yr Bond

    1.3700
    +0.0390 (+2.93%)
     
  • Vix

    20.76
    +2.07 (+11.08%)
     
  • GBP/USD

    1.3734
    -0.0063 (-0.4546%)
     
  • USD/JPY

    109.9700
    +0.2520 (+0.2297%)
     
  • BTC-USD

    47,335.02
    -110.80 (-0.23%)
     
  • CMC Crypto 200

    1,198.07
    -27.47 (-2.24%)
     
  • FTSE 100

    6,963.64
    -63.84 (-0.91%)
     
  • Nikkei 225

    30,500.05
    +176.71 (+0.58%)
     

Why aTyr Pharma Shares Are Continuing To Surge Higher Today

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

aTyr Pharma Inc (NASDAQ: LIFE) is trading significantly higher Tuesday after multiple analyst firms maintained bullish ratings on the stock and raised their respective price targets following the company's announcement that the Phase 1b/2a clinical trial of ATYR1923 in pulmonary sarcoidosis met its primary endpoint.

  • HC Wainwright & Co. analyst Joseph Pantginis maintained aTyr Pharma with a Buy rating and raised the price target from $13 to $18.

  • Oppenheimer analyst Hartaj Singh maintained aTyr Pharma with an Outperform rating and raised the price target from $14 to $20.

  • Roth Capital analyst Zegbeh Jallah maintained aTyr Pharma with a Buy rating and raised the price target from $20 to $21.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. It focuses on the extracellular functionality and signaling pathways of tRNA synthetases.

LIFE Price Action: aTyr Pharma is making new 52-week highs in trading today.

The stock was up 23.40% at $11.28 at time of publication.

Photo: Belova59 from Pixabay.

Latest Ratings for LIFE

Sep 2021

Roth Capital

Maintains

Buy

Sep 2021

Oppenheimer

Maintains

Outperform

Sep 2021

HC Wainwright & Co.

Maintains

Buy

View More Analyst Ratings for LIFE
View the Latest Analyst Ratings

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.